Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver Disease

Exclusion Criteria

• •1. Any known cause of liver disease other than NAFLD as confirmed by patient's history, laboratory data, and/or histological findings.
• •2. Decompensated liver cirrhosis based on laboratory data and clinical manifestations (varices, ascites, or encephalopathy).
• •3. Any previous experimental interventional treatment of NAFLD or NASH within the past 3 months.
• •4. Pre-existing diseases/conditions that could interfere with the results or the completion of this trial based on the investigator's judgment.
• •5. Unstable metabolic syndrome and other serious chronic medical conditions.
• •6. Unstable type 2 diabetes (any of the following):
• •* Requiring medication adjustment within the last 3 months.
• •* Patients requiring GLP-1 agonists treatment.
• •* No more than 10% modification in insulin dose if on insulin.
• •* If on SGLT-2 inhibitors, need to be on stable dose with more than 5% weight loss in the last 3 months.
• •7. Unable to adhere to out-patient clinic management program.
• •8. Do not speak English on a daily-user level.
• •9. Pregnant or planning to become pregnant within the following 6 months.
• •10. Active substance use disorder.
• •11. Does not accept follow-ups over 1 year from time of inclusion (T0).
• •12. Inmates.